Evolving options for the treatment of metastatic breast cancer: Progression-free survival as an endpoint
Cancer Treatment Reviews2011Vol. 37(7), pp. 495–504
Citations Over TimeTop 21% of 2011 papers
Related Papers
- → Surrogate endpoints in randomized cardiovascular clinical trials(2010)16 cited
- → Trends in Utilization of Surrogate Endpoints in Contemporary Cardiovascular Clinical Trials(2016)15 cited
- On the use of laboratory markers as surrogates for clinical endpoints in the evaluation of treatment for HIV infection.(1990)
- → Abstract 19637: Two Decades of Cardiovascular Trials With Primary Surrogate Endpoints: 1990- 2011(2015)
- [Surrogate endpoints].(1999)